Table 3.
Characteristic | Survivors (n = 6) | Non-survivors (n = 12) | p |
---|---|---|---|
Age (years) | 57 ± 16 | 61 ± 10 | 0.486 |
Males | 6 (100) | 8 (67) | 0.245 |
Duration of symptoms (days) | 2.3 ± 1.5 | 1 ± 0.1 | 0.09 |
Extremities affected | 0.005* | ||
Bilateral upper | 3 (50) | 1 (8) | |
Bilateral lower | 1 (17) | 11 (92) | |
Both upper and lower | 2 (33) | 0 | |
Comorbidity | |||
Diabetes mellitus | 1 (17) | 2 (17) | 1 |
ESRD | 0 | 3 (25) | 0.515 |
CLD | 2 (33) | 9 (75) | 0.141 |
Liver cirrhosis | 2 (33) | 7 (58) | 0.31 |
Hepatitis B virus or hepatitis C virus | 1 (17) | 6 (50) | 0.152 |
Data are mean ± standard deviation or number (%)
CLD chronic liver diseases: liver cirrhosis, hepatitis B virus, or hepatitis C virus
* p < 0.05